Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

A new study has confirmed that weight loss or bariatric surgery is safe and very effective, and, for a large percentage of ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

The deal complements Jabil’s specialty in injectable drug delivery systems, like those used for popular GLP-1 diabetes drugs ...

A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...